Calpine (CPN) Misses Q1 EPS by 1c; Boosts FY12 EBITDA Outlook

Calpine (NYSE: CPN) reported Q1 EPS of ($0.14), $0.01 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.33 billion.

Raises FY12 EBITDA outlook from $1.6 - $1.725 billion to a range of $1.675 - $1.8 billion.

For earnings history and earnings-related data on Calpine (CPN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'